[July 21, 2011]

Research and Markets: Obsessive-Compulsive Disorder - Pipeline Review, Q2 2011

Research and Markets (http://www.researchandmarkets.com/research/2cbbe2/obsessivecompulsi) has announced the addition of Global Markets Direct's new report "Obsessive-Compulsive Disorder - Pipeline Review, Q2 2011" to their offering.

'Obsessive-Compulsive Disorder - Pipeline Review, Q2 201', provides an overview of the Obsessive-Compulsive Disorder therapeutic pipeline. This report provides information on the therapeutic development for Obsessive-Compulsive Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Obsessive-Compulsive Disorder. 'Obsessive-Compulsive Disorder - Pipeline Review, Q2 2011' is built using data and information sourced from proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources

Scope

• A snapshot of the global therapeutic scenario for Obsessive-Compulsive Disorder.
• A review of the Obsessive-Compulsive Disorder products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Coverage of products based on various stages of development ranging from discovery till registration stages.
• A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
• Coverage of the Obsessive-Compulsive Disorder pipeline on the basis of therapeutic class, route of administration and molecule type.
• Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
• Key discontinued pipeline projects.
• Latest news and deals relating to the products.

For more information visit http://www.researchandmarkets.com/research/2cbbe2/obsessivecompulsi.

[ Back To TMCnet.com's Homepage ]